Sector revisions Neurizon Therapeutics Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:40:31 09/07/2025 am IST			5-day change	1st Jan Change
0.1600 ^AUD	+3.23%		+3.23%	-5.88%

03/07	Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel	MT
02/07	Neurizon Therapeutics Secures License Deal With Animal Health Company; Shares Up 3%	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
NEURIZON THERAPEUTICS LIMITED	-	-	-	-	-	-	1
ELI LILLY AND COMPANY							27
JOHNSON & JOHNSON							23
ABBVIE INC.							27
NOVO NORDISK A/S							22
ROCHE HOLDING AG							20
NOVARTIS AG							19
ASTRAZENECA PLC							20
MERCK & CO., INC.							24
AMGEN INC.							28
PFIZER, INC.							23
GILEAD SCIENCES, INC.							26
VERTEX PHARMACEUTICALS INCORPORATED							28
SANOFI							23
BRISTOL-MYERS SQUIBB COMPANY							22
GSK PLC							19
CHUGAI PHARMACEUTICAL CO., LTD.							14
JIANGSU HENGRUI MEDICINE CO., LTD.							18
TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
Average							21
Weighted average by Cap.							23